Anticoagulation therapy for hospitalized patients: Patterns of use, compliance with national guidelines, and performance on quality measures

American Journal of Health-System Pharmacy

Volumn 68, Issue 13, 2011, Pages 1239-1244

  Tiryaki, Funda ^a   Nutescu, Edith A ^b   Hennenfent, Joel A ^c   Karageanes, Annette M ^d   Koesterer, Larry J ^e   Lambert, Bruce L ^a   Schumock, Glen T ^f  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Antithrombosis Center   (United States)

^c Aspen Healthcare Metrics   (United States)

^d BEAUMONT HOSPITAL   (United States)

^e ASCENSION HEALTH   (United States)

^f Center for Pharmacoeconomic Research   (United States)

Author keywords

Acute coronary syndrome; Anticoagulants; Compliance; Drug use; Enoxaparin; Hemorrhage; Heparin; Hospitals; Joint commission on accreditation of healthcare organizations; Prescribing; Protocols; Quality assurance; Toxicity; Venous thromboembolism

Indexed keywords

DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ACUTE CORONARY SYNDROME; ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; DRUG INDICATION; FEMALE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT COMPLIANCE; PATIENT MONITORING; PATIENT SAFETY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY CONTROL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 79960172889     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100543     Document Type: Article

References (17)

1. Institute for Healthcare Improvement. Reduce adverse drug events involving anticoagulants. www.ihi.org/IHI/Topics/PatientSafety/ MedicationSystems/Changes/Reduce+Adverse+Drug+Events+Involving+Anticoagulants. htm (accessed 2011 Apr 11).
2. Geerts WH, Bergqvist D, Pineo GF et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008; 133(6 suppl):381S-453S.
3. The Joint Commission. Venous thromboembolism. www.jointcommission.org/ venous-thromboembolism (accessed 2009 Nov 4).
4. Cohen AT, Tapson VF, Bergmann JF et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008; 371:387-94. (Pubitemid 351173321)
5. Tapson VF, Decousus H, Pini M et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest. 2007; 132:936-45.
6. Yu HT, Dylan ML, Lin J et al. Hospitals' compliance with prophylaxis guidelines for venous thromboembolism. Am J Health-Syst Pharm. 2007; 64:69-76. (Pubitemid 46395711)
7. Peterson ED, Roe MT, Mulgund J et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA. 2006; 295:1912-20.
8. American Hospital Association. AHA guide. Washington, DC: AHA Press; 2009.
9. Anderson JL, Adams CD, Antman EM et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction. Circulation. 2007; 116:e148-304.
10. Antman EM, Hand M, Armstrong PW et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. Circulation. 2008; 117:296-329.
11. Lovenox (enoxaparin) package insert. Bridgewater, NJ: Sanofi-Aventis; 2009 Dec.
12. Fragmin (dalteparin) package insert. New York: Pfizer; 2007 Apr.
13. Nutescu EA, Spinler SA, Wittkowsky A et al. Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings. Ann Pharmacother. 2009; 43:1064-83.
14. Vats V, Nutescu EA, Theobald JC et al. Survey of hospitals for guidelines, policies, and protocols for anticoagulants. Am J Health-Syst Pharm. 2007; 64:1203-8. (Pubitemid 46849311)
15. Caprini JA, Tapson VF, Hyers TM et al. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs. J Vasc Surg. 2005; 42:726-33. (Pubitemid 41483500)
16. Qazizada M, McKaba J, Roe M. Hospital-acquired venous thromboembolism: a retrospective analysis of risk factor screening and prophylactic therapy. Hosp Pharm. 2010; 45:122-8.
17. Ten Berg MJ, van den Bemt PM, Huisman A et al. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin. Ann Pharmacother. 2009; 43:1405-12.